Argo Blockchainの空売り状況は、投資家がArgo Blockchainの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Argo Blockchain (NASDAQ:ARBK) 株価情報, 空売り情報

Argo Blockchain

Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.

Argo Blockchain plc - American Depositary Shares

Argo Blockchain PLC

ARGO BLOCKCHAIN PLC by Argo Blockchain Plc

Argo Blockchain plc - 8.75% Senior Notes due 2026

Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies
Career focused on driving business growth and developing an integrated commercial strategy to deliver results
ISELIN, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Rx-ipauQbHp0RYHUWHsNH_Slrg1M7dQAfLScDZO2S22swiv5-OqiF0_q0AiTcN2lOaoGCUbZjjMBJzSLaTOKOSv9PQ5g03wc_wSuz1921F0-o-1KSMFMZabQXdm_4ULo">Outlook Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the appointment of Bob Jahr as Chief Executive Officer (CEO). Mr. Jahr has also been appointed to the Outlook Therapeutics Board of Directors. Lawrence A. Kenyon, who has served as Outlook Therapeutics' Chief Financial Officer (CFO) and interim CEO, will continue serving as CFO and as a member of the Board of Directors.

News

Management

OTLK

Outlook Therapeutics Appoints Bob Jahr As CEO

WIIM

WOLF

Wolfspeed shares are trading higher after the company initiated its pre-packaged restructuring process.

ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>), the industry leader in reimagined British classics and bespoke performance vehicles, is proud to announce two major victories on the national automotive stage. The company's highly acclaimed Jaguar E-Type "The Wellesley Commission" earned First Place at the Larz Anderson Auto Museum's British Car Day, while its first custom Ford Mustang build, Project Ghost '67, took home Best of Class at the 2025 Route 66 Road Fest in Tulsa, Oklahoma.

ECDA

ECD Automotive Design Wins National Awards For Custom Jaguar E-Type And Ford Mustang Builds

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

MARA

MARA Targeting 75 Exahash By End Of 2025, Representing 40% Growth Over 2024; Says 211 Blocks Won In June, Increased BTC Holdings To 49,940 BTC

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said Rio Tinto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) has a big yield and recommended buying the stock. &#8220;I believe in the minerals. I think you're fine,&#8221; he added.
As per the recent news, Rio Tinto and Hancock Prospecting announced on June 24 a joint investment of $1.61 billion to develop the Hope Downs 2 iron ore project in Western Australia&#8217;s Pilbara region. A 50-50 investment will drive a significant expansion of the long-standing Hope Downs Joint Venture between the two companies.
Cramer said TG Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>) is a buy.
Supporting his view, the company, on May 5, reported first-quarter sales of $120.86 million, up from $63.47 million a year ago, beating the consensus of $118.43 million.
Michael S. Weiss, TG Therapeutics Chairman and Chief Executive Officer, stated, "2025 is off to a strong start, and I'm incredibly proud of the progress made thus far. Our performance in the first quarter, including BRIUMVI's $119.7 million in U.S. net sales, demonstrates the growing confidence in our treatment and the increasing adoption by healthcare providers.&#8221;
&#8220;This momentum, combined with the positive feedback we're hearing from both patients and clinicians, reinforces our belief that we can achieve our long-term goal of BRIUMVI becoming the number one prescribed anti-CD20 treatment based on dynamic market share," he added.
Price Action:
<ul class="wp-block-list">
<li>Rio Tinto shares fell 0.7% to settle at $58.33 on Monday.</li>
<li>TG Therapeutics shares declined 2% to close at $35.99.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46169288/5-stocks-in-the-spotlight-wall-streets-most-accurate-analysts-weigh-in">5 Stocks In The Spotlight: Wall Street&#8217;s Most Accurate Analysts Weigh In</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Media

Trading Ideas

TGTX

Cramer Backs This Mining Giant After $1.6B Bet

CLRO

ClearOne shares are trading higher. The company announced it will issue a one-time special stock dividend on July 18.

Melius Research analyst Scott Davis initiates coverage on Carrier Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARR#NYSE">CARR</a>) with a Hold rating and announces Price Target of $90.

Price Target

Initiation

Analyst Ratings

CARR

Melius Research Initiates Coverage On Carrier Global with Hold Rating, Announces Price Target of $90

Envoy Medical&#xAE; Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCH#NASDAQ">COCH</a>) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of three new patents, further strengthening its intellectual property portfolio in Australia.
The Australian Patent Office has issued the following three patents to Envoy Medical Corporation:
<ul>
<li>Australian Patent No. 2021391396 on April 24, 2025. The title of the patent is Implantable Cochlear Implant Stimulation Calibration. This patent relates to cochlear implant systems having a testing circuit that determines an amount of current provided by a source element of the system. The source element can be adjusted to calibrate an amount of current provided by the system during stimulation.</li>
<li>Australian Patent No. 2021390456, on May 8, 2025. The title of the patent is Combination Hearing Aid and Cochlear Implant System. This patent relates to cochlear implant systems that update operations to compensate for the presence of an external hearing aid to improve simultaneous operation of the cochlear implant system and the external hearing aid and prevent the hearing aid from skewing sounds perceived by a wearer.</li>
<li>Australian Patent No. 2022227534, on May 22, 2025. The title of the patent is Recharge System for Implantable Battery. This patent relates to systems and methods for predicting a cumulative thermal dose associated with charging an implanted rechargeable battery and monitoring charging parameters such as temperature to minimize battery charging time while maintaining safe thermal conditions.</li>
</ul>

Global

Envoy Medical, Inc. - Class A Common Stock

COCH

Envoy Medical Secures 3 New Australian Patents For Advanced Cochlear Implant Technologies

TD SYNNEX Acquires Apptium, Terms Not Disclosed

AREB

American Rebel Holdings Announces Retail Authorization Of Its American Rebel Light Beer At 62 Minuteman Food Mart Locations In North And South Caroline

Ramaco Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>, METCB))) ("Ramaco Resources" or the "Company") is pleased to announce that the Fluor Corporation ("Fluor") will deliver its full Preliminary Economic Assessment ("PEA") of Ramaco's Brook Mine on or before July 8, 2025. Today, Fluor has provided Ramaco with the summary results of that report which the Company is disclosing in a separate letter to Shareholders from Ramaco's Chairman and Chief Executive Randall Atkins.
The Fluor PEA states that the project is both commercially and technologically feasible. This report marks a significant step forward and builds on Fluor's earlier interim preliminary techno-economic analysis. The Brook Mine holds what is believed to be the nation's largest&nbsp;unconventional deposit of rare earth elements and critical minerals sourced from coal and carbonaceous ore.

METC

Fluor Confirms $1.2B Value For Ramaco's Brook Mine, Validating Feasibility Of Nation's Largest Unconventional Rare Earth Deposit

UBS analyst Michael Goldsmith initiates coverage on Kite Realty Gr Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRG#NYSE">KRG</a>) with a Neutral rating and announces Price Target of $24.

UBS Initiates Coverage On Kite Realty Gr Trust with Neutral Rating, Announces Price Target of $24

Dyne Therapeutics shares are trading lower after the company announced a $200 million public offering.

Wolfe Research analyst Andy Chen initiates coverage on Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) with a Outperform rating and announces Price Target of $170.

VRNA

Wolfe Research Initiates Coverage On Verona Pharma with Outperform Rating, Announces Price Target of $170

ATAI

Atai Life Sciences shares are trading higher after the company announced it raised $50 million via a private placement.

Richtech Robotics Added To Russell 2000 And Russell 3000 Indices

Contracts

MNTS

Momentus Signs Contract With Orbit Fab To Provide Hosted Payload Services For On-Orbit Demonstration Of Podracer

The Brook Mine will also be first new coal mine in Wyoming in over 50 years
RANCHESTER, Wyo., July 1, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>, METCB, ", Ramaco", or the ", Company", ))) and Ramaco Rare Earth, LLC will host a landmark ribbon cutting and groundbreaking ceremony on Friday, July 11, to commemorate the opening of the Brook Mine Carbon Ore Rare Earth project. It will be the first new rare earth mine in the United States in more than 70 years and first new coal mine in Wyoming in over 50 years.
The event, themed "American Independence: A Rare Earth Revolution," will take place at Ramaco's iCAM Technology Center in Ranchester, Wyoming, and is scheduled to feature remarks from national and state leaders. This includes U.S. Secretary of Energy Chris Wright, Wyoming Governor Mark Gordon, U.S. Senators John Barrasso and Cynthia Lummis, U.S. Representative Harriet Hageman and former U.S. Senator and Ramaco Board member Joe Manchin.

Ramaco To Open First New U.S. Rare Earth Mine In 70 Years, First New Wyoming Coal Mine In Over 50 Years

<h3>Gainers</h3>
<ul>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares increased by 10.3% to $1.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $97.2 million. </li>
<li>Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) shares increased by 10.26% to $0.46. The company's market cap stands at $77.8 million. </li>
<li>Melco Resorts and Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) stock moved upwards by 9.95% to $7.95. The company's market cap stands at $3.0 billion. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) shares rose 9.91% to $1.33. The market value of their outstanding shares is at $30.5 million. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) stock rose 8.69% to $1.5. The company's market cap stands at $41.6 million. </li>
<li>Classover Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDZ#NASDAQ">KIDZ</a>) stock moved upwards by 8.5% to $3.19. The market value of their outstanding shares is at $69.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Massimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) stock fell 18.9% to $1.8 during Tuesday's pre-market session. The market value of their outstanding shares is at $92.2 million. </li>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) shares declined by 8.42% to $0.96. The company's market cap stands at $1.8 million. </li>
<li>Neo-Concept International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) stock decreased by 8.12% to $2.15. The company's market cap stands at $9.5 million. </li>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) stock declined by 7.69% to $1.08. The market value of their outstanding shares is at $20.6 million. </li>
<li>Jinxin Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMI#NASDAQ">NAMI</a>) stock declined by 6.74% to $0.97. The company's market cap stands at $71.1 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares decreased by 6.1% to $7.7. The market value of their outstanding shares is at $276.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

KIDZ

KXIN

LESL

MAMO

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

NAMI

RYET

TLYS

ZCMD

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock rose 64.9% to $2.16 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.2 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares rose 48.69% to $5.68. The company's market cap stands at $2.7 million. </li>
<li>Verrica Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRCA#NASDAQ">VRCA</a>) shares rose 21.52% to $0.64. The market value of their outstanding shares is at $49.0 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares increased by 21.13% to $1.26. The market value of their outstanding shares is at $4.4 million. </li>
<li>Mesoblast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) stock moved upwards by 12.85% to $12.29. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) shares rose 10.61% to $0.5. The market value of their outstanding shares is at $103.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pulmatrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PULM#NASDAQ">PULM</a>) shares decreased by 23.9% to $5.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $25.2 million. </li>
<li>SenesTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNES#NASDAQ">SNES</a>) stock decreased by 17.88% to $4.18. The company's market cap stands at $10.2 million. </li>
<li>Genenta Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTA#NASDAQ">GNTA</a>) stock declined by 16.92% to $2.53. The market value of their outstanding shares is at $55.6 million. </li>
<li>Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) stock declined by 16.73% to $11.05. The market value of their outstanding shares is at $7.2 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) stock declined by 14.21% to $6.04. The market value of their outstanding shares is at $44.4 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) stock fell 11.64% to $0.77. The market value of their outstanding shares is at $13.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Argo Blockchain

空売り

Argo Blockchain (NASDAQ:ARBK) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル